Volume 38,Issue 1,2025 Table of Contents

   
Other Issues:  
  

[Topic Research——Gastric and esophageal cancer——Academic Frontier]

Current status and prospect of tracer technology in gastric cancer
  SHEN Xiaofei, GUAN Wenxian
  2025,38(1):1-5 [Abstract(49)]  [View PDF 2.54 M (33)]
  

[Topic Research——Gastric and esophageal cancer——Research progress]

Research progress of hepatocyte nuclear factor 4α in gastric cancer and precancerous lesions
  YANG Yuyan, ZHAO Weihan, WANG Siyu, DONG Siqi
  2025,38(1):6-10 [Abstract(48)]  [View PDF 1.39 M (16)]
  
Expression and effect of P38 mitogen-activated protein kinase and transforming growth factor-β in gastric cancer
  YANG Lu, LI Zixin, CHANG Jianlan
  2025,38(1):11-15 [Abstract(43)]  [View PDF 1.43 M (18)]
  

[Topic Research——Gastric and esophageal cancer——Original Articles]

Efficacy and safety of endoscopic submucosal dissection in the treatment of early cardia cancer and non-cardia cancer with submucosal infiltration
  ZHU Tingting, REN Ximei, YANG Jinping, LI Wenjun, XIANG Ying, XU Guifang
  2025,38(1):16-21 [Abstract(44)]  [View PDF 1.74 M (20)]
  
Clinical effect of endoscopic submucosal dissection in the treatment of Siewert type Ⅱ early adenocarcinoma and precancerous lesions of esophagogastric junction
  GUO Huiwen, HE Qibin, LIU Yang, TIE Guangxuan, CHEN Yijia
  2025,38(1):22-27 [Abstract(43)]  [View PDF 2.47 M (18)]
  
Efficacy and safety of apatinib in the second-line treatment of advanced gastric cancer
  GUO Mengya, CHEN Yue, PENG Weiwei, SHA Huanhuan, FANG Ying, ZHOU Guoren
  2025,38(1):28-32 [Abstract(36)]  [View PDF 1.45 M (15)]
  
Short-term efficacy and safety of sintilimab combined with oxaliplatin and capecitabine as neoadjuvant therapy for locally advanced gastric cancer
  ZHANG Shuai, LIU Liangliang, HUANG Di, SHENG Ru, DU Xuetao, LI Shuguang, HU Nan, ZHAO Yifeng
  2025,38(1):33-36,41 [Abstract(39)]  [View PDF 1.17 M (13)]
  
Efficacy and safety of oxaliplatin and capecitabine in combination with sintilimab as first-line treatment for HER2-negative advanced gastric cancer
  ZHANG Xiaorui, SHAN Haixia, ZHU Zhengqiu
  2025,38(1):37-41 [Abstract(36)]  [View PDF 1.31 M (12)]
  
Clinical efficacy and safety of PD-1 inhibitor combined with apatinib in the third line treatment of HER2-negative advanced gastric cancer
  XU Hongmei, CHEN Lanlan, ZHOU Tao, GAO Liming
  2025,38(1):42-47 [Abstract(40)]  [View PDF 1.48 M (18)]
  
Influencing factors of lymph node metastasis and construction of a nomogram prediction model in elderly patients with early gastric cancer
  LIANG Yufei, LI Chunying, ZOU Han, TIAN Liang, LI Xinmeng
  2025,38(1):48-52 [Abstract(32)]  [View PDF 1.70 M (12)]
  
Predictive value of prealbumin combined with neutrophil-to-lymphocyte ratio in early postoperative complications of gastric cancer
  GUO Maosen, LI Hu, GAO Fei, HAN Bin
  2025,38(1):53-56 [Abstract(33)]  [View PDF 1.14 M (15)]
  
Prognostic value of peripheral blood neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with gastric cancer
  ZHANG Le, LI Wei, HUANG Zeping, WANG Wenjie, CHEN Xiao
  2025,38(1):57-61,66 [Abstract(34)]  [View PDF 1.57 M (13)]
  
Analysis of risk factors of acute respiratory failure after radical resection of esophageal cancer by two methods
  LEI Xiuwen, ZHU Xiaolei, TIAN Long
  2025,38(1):62-66 [Abstract(34)]  [View PDF 1.23 M (11)]
  
Diagnostic value of three evaluation systems for medium-to-high risk carcinogenesis in chronic atrophic gastritis
  CAO Yanli, PAN Hongnian, LIU Xiaoyan, WANG Xiuzhong
  2025,38(1):67-71 [Abstract(32)]  [View PDF 1.62 M (14)]
  
Expression and clinical significance of IGFBP7 and TGFβ1 in esophageal squamous cell carcinoma
  REN Huaijing, MA Zhenqi, WANG Xuehong, TAO Jianan
  2025,38(1):72-76 [Abstract(31)]  [View PDF 1.74 M (15)]
  
Effect of Porphyromonas gingivalis up-regulating Src protein expression on proliferation, migration and invasion of esophageal squamous cell carcinoma
  GUO Yijun, GAO Shegan, SHI Linlin
  2025,38(1):77-81 [Abstract(31)]  [View PDF 2.92 M (13)]
  
Relationship between puerarin and urothelial carcinoembryonic antigen 1 expression in apoptosis and autophagy of esophageal cancer cells
  LI Jing, WANG Jumei, TIAN Jingrong, BI Lihua, GAO Yuanyuan, SHANG Hong
  2025,38(1):82-86 [Abstract(33)]  [View PDF 2.08 M (16)]
  

[Special Articles]

From protease inhibitors to integrase strand transfer inhibitors: the evolution of HIV drug resistance management
  HU Zhiliang, YANG Yongfeng
  2025,38(1):87-92 [Abstract(34)]  [View PDF 2.66 M (17)]
  

[Clinical Original Articles]

Efficacy and safety of avatrombopag in the treatment of thrombocytopenia: a Meta-analysis
  PENG Jincheng, XIA Quan, LIU Changwei, PENG Can, FANG Ling
  2025,38(1):93-99 [Abstract(57)]  [View PDF 1.33 M (16)]
  
Clinicopathological features of thyroid Hürthle cell neoplasm in 73 cases
  WANG Cuizhong, ZHONG Yichen, SHEN Tong, RUI Qiang, WANG Chenxi, JIANG Zhiwei, GONG Guanwen
  2025,38(1):100-104 [Abstract(33)]  [View PDF 593.96 K (12)]
  
Predictive role of serum interleukin-37 on prognosis of patients with acute exacerbation of chronic obstructive pulmonary disease
  SU Xi, SUI Fengqiu, WANG Yongming, LIU Mingxia
  2025,38(1):105-109 [Abstract(27)]  [View PDF 759.28 K (15)]
  
Comparison of efficacy and safety of doxycycline versus azithromycin for mycoplasma pneumonia in children over 8 years old
  WANG Shengquan, HUA Ying, SUN Mingxia, MA Jiawei, ZHANG Weihong, WU Guoqin, LIU Ji
  2025,38(1):110-112,117 [Abstract(31)]  [View PDF 563.77 K (19)]
  
Short- and long-term effects of microwave ablation and radiofrequency ablation on nodule volume and thyroid function in patients with benign thyroid nodules
  HAN Xiaojun, GUO Daoning, WANG Ning
  2025,38(1):113-117 [Abstract(26)]  [View PDF 719.46 K (12)]
  
Multiple incision contradrainage and necrotic fascia resection in the treatment of severe necrotizing fasciitis of thoracic and abdominal wall
  ZHOU Zhengyun, ZHANG Pengjun, CHENG Jianzhang, WANG Shufeng,, TANG Haili
  2025,38(1):118-121 [Abstract(26)]  [View PDF 1.73 M (14)]
  
Impact of midwife-led experience delivery mode on the pregnancy outcomes of primiparas
  WEI Suhua, LUO Fengmei, LI Xiuhua, SHI Xiaohong, ZOU Li
  2025,38(1):122-125 [Abstract(26)]  [View PDF 670.45 K (14)]
  

[Chinese Medicine · Integrative Medicine]

Professor Wu Chengyu's experience in treating malignant tumors with balanced thinking
  ZHANG Wen, GE Linlin, WU Chengyu
  2025,38(1):126-129 [Abstract(24)]  [View PDF 672.40 K (13)]
  

[Management Discussion]

Analysis and countermeasures of electronic data entry problems in phase Ⅰ clinical trials
  WANG Lili, LIANG Hong, ZHANG Jing, WANG Qianqian, HE Jinjie, CHEN Yuancheng, YU Jicheng, ZHANG Jiyin
  2025,38(1):130-133,137 [Abstract(27)]  [View PDF 594.69 K (13)]
  

[Case Report]

以全身多处皮肤变硬为主要表现的浆细胞病1例
  周青飒,严冰
  2025,38(1):134-137 [Abstract(31)]  [View PDF 2.38 M (24)]
  

[Overview]

Application of digital medicine in chronic disease management
  WU Rui, XU Ling, HAN Qingfeng
  2025,38(1):138-141 [Abstract(32)]  [View PDF 633.39 K (17)]
  
Advances on the mechanism of ubiquitination in gliomas
  LIU Chenxi, ZOU Shucheng
  2025,38(1):142-145,150 [Abstract(33)]  [View PDF 571.82 K (15)]
  
Treatment status and progress of patent ductus arteriosus in extremely low gestational age newborns and extremely low birth weight infants
  ZHANG Yuhan, GAO Shuqiang, JU Rong
  2025,38(1):146-150 [Abstract(33)]  [View PDF 585.15 K (14)]
  
Treatment of plasma cell mastitis
  YANG Meining,WANG Fang
  2025,38(1):151-154.160 [Abstract(42)]  [View PDF 868.75 K (26)]
  
Research progress of NLRP3 inflammasome activation in arthritic diseases
  LIANG Feng, WU Yi, SHEN Siyuan, XIAO Shouyun, CHEN Xinkun, ZHANG Yunpeng, TIAN Jiwei, DING Huimin
  2025,38(1):155-160 [Abstract(32)]  [View PDF 1.25 M (12)]
  

Scan with WeChat

Scan with WeChat